BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ICT-107: Additional Phase I data

Additional data from a U.S. Phase I trial showed that 6 of 16 newly diagnosed GBM patients treated with intradermal ICT-107 plus standard of care (surgery, radiation and chemotherapy) were disease-free...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >